The accumulation of fetuin-A-containing calciprotein particles (CPP) in the serum of patients with renal disease and those with chronic inflammation may be involved in driving sterile inflammation and extraosseous mineral deposition. We previously showed that both fetuin-A and CPP were present in the peritoneal dialysis (PD) effluent of stable PD patients. It is unknown whether different PD fluids might affect the formation of CPP in vivo.
Method
Peritoneal effluent from 12 patients was collected after a 6-hour dwell with 7 different commercial PD fluids. Calciprotein particles and inflammatory cytokines were measured by flow cytometry.
Results
High inter-subject variability in CPP concentration was observed. Peritoneal dialysis fluids containing 1.75 mmol/L calcium were associated with enhanced formation of CPP in vivo, compared with fluids containing 1.25 mmol/L calcium. Osmotic agent, fluid pH, and glucose concentration did not affect CPP formation. Peritoneal dialysis effluent CPP levels were not associated with changes in inflammatory cytokines.
Conclusion
High calcium-containing PD fluids favor intraperitoneal CPP formation. This finding may have relevance for future PD fluid design.
SchinkeT., AmendtC., TrindlA., PöschkeO., Müller-EsterlW., Jahnen-DechentW.The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis.J Biol Chem1996; 271(34): 20789–96.
2.
HeissA., DuChesneA., DeneckeB., GrötzingerJ., YamamotoK., RennéT.Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.J Biol Chem2003; 278(15): 13333–41.
3.
CaiM.M.X., SmithE.R., HoltS.G.The role of fetuin-A in mineral trafficking and deposition.Bonekey Rep2015; 4(MAY): 672.
4.
HoltS.G., SmithE.R.Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease.Nephrol Dial Transplant2016; 31(10): 1583–7.
5.
HeissA., EckertT., AretzA., RichteringW., van DorpW., SchäferC.Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles.J Biol Chem2008; 283(21): 14815–25.
6.
PaschA., FareseS., GräberS., WaldJ., RichteringW., FloegeJ.Nanoparticle-based test measures overall propensity for calcification in serum.J Am Soc Nephrol2012; 23(10): 1744–52.
7.
SmithE.R., HanssenE., McMahonL.P., HoltS.G.Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage.PLOS One2013; 8(4): e60904.
8.
AghagolzadehP., BachtlerM., BijarniaR., JacksonC., SmithE.R., OdermattA.Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.Atherosclerosis2016; 251: 1–11.
9.
HamanoT., MatsuiI., MikamiS., TomidaK., FujiiN., ImaiE.Fetuinmineral complex reflects extraosseous calcification stress in CKD.J Am Soc Nephrol2010; 21(11): 1998–2007.
10.
SmithE.R., FordM.L., TomlinsonL.A., RajkumarC., McMahonL.P., HoltS.G.Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.Nephrol Dial Transplant2012; 27(5): 1957–66.
11.
SmithE.R., FordM.L., TomlinsonL.A., BodenhamE., McMahonL.P., FareseS.Serum calcification propensity predicts all-cause mortality in predialysis CKD.J Am Soc Nephrol2014; 25(2): 339–48.
12.
CaiM.M., WiggB., SmithE.R., HewitsonT.D., McMahonL.P., HoltS.G.Relative abundance of fetuin-A in peritoneal dialysis effluent and its association with in situ formation of calciprotein particles: an observational pilot study.Nephrology (Carlton)2015; 20(1): 6–10.
13.
SmithE.R.The isolation and quantitation of fetuin-A-containing calciprotein particles from biological fluids. In: HewitsonT.D., BeckerG.J., eds. Kidney research: experimental protocols, methods in molecular biology.New York: Springer; 2016: 221–40.
14.
SmithE.R., HewitsonT.D., CaiM.M.X., AghagolzadehP., BachtlerM., PaschA.A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.Sci Rep2017; 7(1): 5686.
15.
SmithE.R., HewitsonT.D., CaiM.M.X., HoltS.G.Fetuin-A in the peritoneal effluent of patients with encapsulating peritoneal sclerosis—more than a protein?Kidney Int2017; 92(5): 1289–90.
16.
OliveiraE., AraújoJ.E., Gómez-MeireS., LodeiroC., Perez-MelonC., Iglesias-LamasE.Proteomics analysis of the peritoneal dialysate effluent reveals the presence of calcium-regulation proteins and acute inflammatory response.Clin Proteomics2014; 11(1): 17.
17.
ZavvosV., BuxtonA.T., EvansC., LambieM., DaviesS.J., TopleyN.A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.Kidney Int2017; 1–15.
18.
WilkieM.Exploring the association between icodextrin and encapsulating peritoneal sclerosis.Perit Dial Int2011; 31(3): 259–62.
19.
EddingtonH., HurstH., RamliM.T., SpeakeM., HutchisonA.J.Calcium and magnesium flux in automated peritoneal dialysis.Perit Dial Int2009; 29(5): 536–41.
